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Whilst guidelines recommend palliative care in non-cancer conditions, this has not been widely 
implemented. We examined whether the recording of a palliative care approach and the numbers of 
hospital deaths for deceased patients with heart failure, dementia, chronic obstructive pulmonary 
disease (COPD) and cancer have changed since the UK End of Life Care Strategy was introduced.
Methods
We conducted sequential cross-sectional studies of decedents within the UK’s Clinical Practice 
Research Datalink and Hospital Episode Statistics.  All adults with a primary care record of COPD 
(N=5,426), dementia (N=7,339), heart failure (N=6,409) or cancer (N=18,668) who died during three 
one-year periods (April 2009-March 2014) were included. Evidence of a palliative care approach was 
identified from primary care records, and death in hospital from secondary care data.  
Results
From 2009 to 2014, proportions with a primary care record of palliative care increased for COPD 
from 13.6% to 21.2%; dementia from 20.9% to 40.7%; and heart failure from 12.6% to 21.2%; but 
remained substantially lower than for cancer (57.6% to 61.9%).  Median days before death of 
recording improved for COPD (145 to 224) and dementia (44 to 209); but not for heart failure (168.5 
to 153) and cancer (123 to 114).  Trends in hospital deaths were not consistently downward, 
although the proportions of patients dying in hospital were lower in the last period compared to the 
first.
Conclusions
Recording of a palliative care approach for non-cancer conditions has increased since the 
introduction of the UK End of Life Care Strategy, but remains inadequate. 
Page 2 of 40
https://mc.manuscriptcentral.com/bmjspcare





























































Confidential: For Review Only
3
Introduction
A palliative approach to care is important not only in cancer but in non-malignant conditions where 
patients have palliative care needs comparable to those of cancer patients [1].  Among the most 
common conditions identified by the World Health Organisation as diseases that would benefit from 
palliative care are heart failure (HF), dementia and chronic obstructive pulmonary disease (COPD) 
[2]. Such conditions carry a similar symptom burden and poor quality of life for patients and their 
families and friends, but there is evidence from the United States [3,4], and the United Kingdom (UK) 
[5] that these needs are less likely to be met.  
In the UK, the introduction  of a national End-of-Life Care Strategy in 2008 [6] represented a major 
policy shift to extend specialist palliative care regardless of diagnosis, to be delivered primarily by 
generalists, with access to specialist palliative care services for persistent or complex problems.  
Although the role of primary care is central to providing palliative care to those nearing the end of 
life, information on whether the need is being met in the UK is sparse, despite maintenance of a 
palliative care register by general practitioners being incentivised as part of the Quality and 
Outcomes Framework (QOF) since 2006 [7].  Using general practice-based registers of palliative care, 
one study conducted shortly after the Strategy’s introduction, found patients with HF were poorly 
represented on the register, and when recorded, registration was often within a week of death [8].  
Using the same electronic datasource, Bloom and colleagues showed that whilst the proportion of 
people dying from COPD and receiving palliative care increased between 2005 and 2015, this 
remained disproportionately low in those dying with COPD only (16.5%) compared with those dying 
with COPD and cancer (56.5%) [9].  Although from simple observation, the rate of change appears to 
increase from 2011. 
With the aim of exploring whether recording of palliative care in primary care has changed for non-
cancer conditions since 2008, patients who died with HF, dementia, or COPD, and for comparison, 
patients who died with cancer, in three different years were identified in UK’s Clinical Practice 
Research Datalink (CPRD) [10].  Using information in their healthcare records, potential changes in 
palliative care recording as well as the prevalence of hospital deaths were explored. 
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Materials and Methods
Patients aged 18 or over with at least one clinical record of COPD; dementia; heart failure; or cancer 
(excluding non-melanoma skin cancer) who died in the periods 1 April 2009 to 31 March 2010; 1 
April 2011 to 31 March 2012; or 1 April 2013 to 31 March 2014, were identified in CPRD using Read 
codes described in the NHS’s Quality and Outcomes Framework (QOF) (QOF version 29, June 2014) 
[11]. The CPRD is a database of contemporaneous medical records from UK primary care and is 
demographically representative, covering around c.7% of the UK population [10]; the QOF is a 
voluntary incentive scheme for general practitioners in the UK [7].  Fact and date of death recorded 
in primary care records, which have shown a high level of agreement with national death 
certification, were used to identify patients who had died [12].  Focus was primarily on patients who 
had only one of these conditions; where two or more were recorded, patients were considered in 
two additional groups based on whether or not they had cancer.  Patients were included if they had 
at least one year of records and met CPRD acceptability criteria for data quality; for sensitivity 
analyses, subgroups of patients were established based on whether conditions were recorded either 
within five years of, or in the year before, death.
The palliative care register that has been part of QOF since 2006 covers clinical terms relating to 
palliative care services; advance care directives, recording of preferred place of death, indication of 
terminal illness and similar care near the end of life are not covered.  Therefore, a comprehensive 
list of Read codes that reflected recognition of the need for end of life care was developed 
(Supplementary Table 1).  Patients were considered as recognised as needing palliative approach if 
any of these codes appeared in their primary care records; in addition, the time between the earliest 
recording of any palliative care code and their death was calculated.  Where no palliative care codes 
were recorded, patients were considered as not being recognised as needing palliative approach.
Information on whether patients died in hospital was obtained from secondary care data, which was 
available for 81% of the cohorts who had consented for linkage of CPRD to HES.  From their HES 
records, it was possible to determine whether a patient had died in hospital; otherwise, patients 
were assumed to have died outside hospital.  Patients with no consent for linkage were excluded 
from the analysis of death in hospital.
Proportions recognised as requiring a palliative approach were calculated, and in order to be 
comparable to cancer patients, were standardised to the age- and sex-distribution of cancer patients 
who died in the first year of the study (April 2009-March 2010).  Annual changes in proportions, with 
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95% confidence intervals (CI), were estimated using binomial regression; annual changes in 
proportions were assumed to be linear since all tests for departure from linearity were not 
statistically significant.  All analyses were conducted using Stata 14.2.  
Results
Figure 1 shows how the 47 473 patients included in the sequential cross-sectional studies were 
identified in CPRD, and Table 1, the expected between-disease differences in age and sex 
distributions.  For all conditions except cancer, palliative care codes outside QOF were used as often 
as those in QOF, and hence the totality was used in all presented analyses.
In the first year of our study, around three in every 20 patients with COPD, HF or dementia were 
recorded with a code recognising a palliative approach, compared to 12 in every 20 cancer patients 
(Table 2).  By the final period, April 2013 to March 2014, proportions had increased to four in every 
20 patients with COPD; eight in every 20 with dementia; and five in every 20 with HF.  Palliative care 
recording increased most for patients with dementia, growing by 6.4% per year (95%CI 5.8, 7.0%); 
followed by HF at 2.6% (95%CI 2.0, 3.1%); and COPD at 2.3% (95%CI 1.7, 2.9%).  Over the same 
period, recording among cancer patients grew by 1.1% (95%CI 0.7, 1.5%).  For patients with two or 
more conditions, those without cancer saw an increase from three to six in every 20 patients being 
recorded, and those with cancer from nine to 11 in every 20 (Supplementary Table 2).  Repeating 
analyses with patients whose conditions were recorded within the 5-year or 1-year period before 
death gave marginally greater proportions, mostly due to a smaller number of patients contributing 
to the denominator, but the annual change over time remained the same (data available on 
request).  As for the timing of recording, this changed over the study period (Figure 2).  In the year 
2009-10, 35.8% with dementia and palliative care noted, 22.0% with HF and 16.0% with COPD were 
recorded for the first time in the week before death.  By 2013-14, this had reduced to 17.5%, 15.6% 
and 13.3% for dementia, HF and COPD respectively, becoming closer to the 8-10% of patients with 
cancer.
Palliative care recording generally increased among men and women; in all age groups; and across 
all deprivation categories (Supplemental Table 3).  Overall, proportions with palliative care recorded 
were similar for men and women; however, for dementia, sex-specific proportions diverged such 
that by 2013-14, 43.9% of women compared to 36.2% of men had palliative care recorded.  With 
regards to age, some of the largest increases occurred in those aged 90 or over, with annual change 
estimated at 2.4% (95%CI 0.3, 4.5%) for COPD, and ranging up to 7.2% (95%CI 6.2, 8.2%) for 
dementia.  On the other hand, patients aged under 70 did not see an increase in recording, and for 
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COPD in particular, where around a fifth of deaths occurred in the under 70-year olds, palliative care 
recording was lower than for those aged 70-79, at 16.9% compared to 24.8% in the last period.  For 
those living in more deprived areas, proportions of palliative care recording tended to be lower than 
amongst those from the most affluent, but not always significantly so.
Proportions of patients dying in hospital increased initially before falling in 2013-14, being 
significantly lower in the last year than in the first for cancer, COPD, and dementia but not HF (Table 
3).  When considering whether patients had a primary care record of palliative care, fewer with a 
record died in hospital than those who did not.  Over the course of the study, the only condition 
apart from cancer where the proportions with palliative care who died in hospital decreased was 
dementia.  Repeating the analysis restricted to QOF palliative care register codes, or where patients 
whose first record of palliative care was in the week before death were removed, gave similar 
findings (data not shown).
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Discussion 
Summary of main findings 
It is encouraging that the recognition of the need for palliative care approach has increased in those 
with non-cancer diseases since the introduction of the UK End of Life Care Strategy.  Not only have 
the proportions increased, but the timeliness of recording has also changed, with fewer patients 
registered in the week before death.  Despite the improvements, significant inequalities remain; 
most notably that decedents with these conditions remain less likely to be recorded as having 
palliative care needs than those with cancer.  With regards to dying in hospital, the data suggest that 
the numbers have decreased, particularly among those with palliative care, but a longer trajectory is 
needed to confirm these observations.
Registration on the palliative care QOF is a proxy measure for clinical recognition of the need for a 
palliative approach to care.  Since the introduction of this indicator in 2006, over 99% of practices 
use a palliative care register [7].  Despite clear guidance, there may be a perception that the 
palliative care QOF is for cancer patients.  Interestingly though, not only did the use of QOF palliative 
care codes in the non-malignant conditions increase, but also other non-QOF codes relating to end 
of life care such as advanced care directives were used as often throughout the data.  Some of the 
biggest increases in recording were among patients aged 90 or older.  Socioeconomic differences in 
palliative care were present to a degree, with more deprived patients less likely to have a record of 
palliative care than those who were more affluent; however, among the factors we were able to 
examine, age and GP practice may have been more influential on the recording. 
Comparison with literature 
A realist evaluation of 16 GP Practices showed improvement over time in recognition of palliative 
care in non-cancer conditions following the introduction of a palliative care pathway but, as found 
here, the inequity of lower recognition of palliative care in non-cancer conditions compared to 
cancer remained [13].  Our findings are consistent with the other CPRD study showing that 
recognition of a palliative care approach was driven by a lung cancer diagnosis rather than COPD 
itself [9].  Our slightly higher proportion categorised as palliative care may be because of our use of 
palliative care registration rather than Read codes only.  Other studies have shown a reduction in 
hospital deaths, in both cancer and non-cancer conditions [14–16]. The reasons for these changes 
are likely to be multifactorial: the Strategy and its wider policy influence; public health initiatives; 
increased clinical education and more publications and awareness regarding palliative care for non-
cancer conditions. For reduced hospital deaths in dementia, factors such as economic incentives to 
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reduce hospital admissions and stays have been suggested as a factor in the UK, other European 
countries and the US and have resulted in more deaths in care homes [16]. This study did not 
explore death outside of hospital but a study of hospice deaths from 1993–2012 demonstrated an 
increase in non-cancer conditions among hospice decedents although absolute numbers remain 
small [17]. 
 
Strengths and limitations 
This study benefits not only from being population-based in a large primary care dataset, but also 
from having as its basis the contemporaneous recording of conditions and care by general 
practitioners and health care professionals.  We were able to identify decedents who had a record of 
the conditions of interest in their primary care notes, rather than relying on causes of death on the 
death certificates which are k own to be inaccurate [18].  Moreover, the conditions of interest-  
cancer, heart failure, dementia and COPD - are QOF indicators, whereby GPs are incentivised to 
maintain the disease registers and record diagnoses once confirmed using specific tests and 
assessments, and have proved reliable for population-based prevalence data [19].  One limitation is 
that since primary care notes were established across patients’ lifetimes, the disease may not have 
been relevant to the patient’s death, and our denominator may be overestimated.  However, 
analyses including only those whose disease was recorded in the last five or final year of life, whilst 
finding slightly higher proportions of palliative care recording showed very similar patterns.  A 
limitation of the cross-sectional design is that general practices contributing to CPRD can change 
over time; restricting the analyses to the 42618 decedents (89.8%) whose practices contributed to 
all three periods did not alter the findings (data not shown).  Many of the general practices 
contributing to CPRD are located in the North West or South East of England, and of smaller practice 
size than the national average [20,21]; however, in terms of the patients, the 7% of the UK 
population in CPRD are generally representative of the total population [10].
Identification of a palliative care approach in this study is dependent on coding in the clinical record; 
whilst a broader range of codes was used than in some recent studies [8,9], it is likely that we have 
under-estimated true palliative care activity. However, systematic differences in this under-
estimation by condition seem unlikely and hence the relative differences observed would remain 
robust. 
Information on place of death is not routinely available in primary care records in CPRD and was 
established from secondary care data. We were therefore only able to define whether patients died 
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in hospital or not; information on deaths at home or hospice were unavailable.  While we had only 
three alternate years of data available due to limitations of funding, this was sufficient to see an 
upward time trend in palliative care recording, described as linear growth but not of sufficient 
duration to assess alternative trend patterns; and when compounded by low palliative care 
recording, to determine clear patterns in hospital deaths.  We also recognise that place of death in 
isolation should not be a quality marker of good care of the dying. Measures such as patient centred 
outcome measures (PCOMs) are increasingly seen as the gold standard for measuring quality of care 
but were not available and indeed are not widely used [22].  Although we relate our discussion to 
the UK End of Life Strategy of 2008, we are unable to assume causality in this observational study 
and data prior to 2008 were not analysed for comparison. Of interest, the rate of increase for COPD 
patients (2.3% per year) is similar to the rate of increase between 2008 to 2014 reported in Bloom et 
al, and which is approximately twice the rate of increase in their 2005 to 2008 data although they 
did not evaluate this [9].
Implications for research, policy and practice 
Although inequities seem to be improving for all disease further investigation of the reasons for and 
how to overcome the inequality are needed: for example, a case study approach of practices with 
low and high proportions of patients on the palliative care register.  Also a study to explore more 
patient-centred outcomes of the result of being on a palliative care register especially as these 
become more widely used, for example the Integrated Palliative care Outcome Scale (IPOS), a
patient centred outcome measure developed and validated for use with people with advanced 
disease [22]. 
We would challenge the current UK strategy for identification of palliative care patients based on 
“end of life”.  Although the UK policy definition does not intend an interpretation of “the last few 
days or weeks of life”, in practice, that is often the case. The use of the word “end” strongly implies a 
time-bound frame, and one which works backwards from the time of death. This risks delay in 
implementing a palliative approach, arising from the real challenges of accurately predicting the day 
of death, so called “prognostic paralysis” [23], a problem that is also well recognised as a barrier to 
hospice care for non-cancer diagnoses in the United States [24].  We welcome initiatives that 
promote supportive care and advance care planning earlier in the disease trajectory [25].  The more 
recent national framework for local implementation UK Ambitions of Care document uses the 
phrase “palliative and end-of-life” [26]. It will be interesting to see whether this clarifies or 
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complicates clinical practice. We look to the WHO and Worldwide Palliative Care Alliance which do 
not mention either diagnosis, or prognosis, rather using the term life-limiting conditions and 
recommends  identification of need for palliative care based on symptoms [2]. 
Conclusions 
To the best of our knowledge this is the first use of this data linkage in the palliative care population 
and allowed us to explore not only recognition of palliative care in primary care. Since the 
introduction of the UK End of Life Care Strategy recognition of the need for palliative care approach 
has increased in common life-limiting conditions, in a timelier manner.  This may have in turn been 
related to a reduction in the number of patients dying in hospital but further study will be needed to 
confirm this.
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Figure Legends
Figure 1: Flow diagram of identification of study subjects from CPRD GOLD.
Figure 2: Distribution of time before death when palliative care first recorded in primary care notes 
by disease and year.
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Table 1: Demographics of persons with cancer, chronic obstructive pulmonary disease (COPD), dementia, or heart failure in their general practice records who died in April 2009-March 2010, 
April 2011-March 2012 or April 2013-March 2014.
Cancer COPD Dementia Heart Failure
2009-10 2011-12 2013-14 2009-10 2011-12 2013-14 2009-10 2011-12 2013-14 2009-10 2011-12 2013-14
Annual Deaths 6799 6386 5483 1924 1872 1630 2433 2474 2432 2429 2152 1828
Sex- Male(%) 51.0% 51.3% 50.4% 53.8% 55.7% 54.4% 32.3% 32.1% 32.0% 47.3% 47.6% 50.2%
Age- Mean(sd) 74.1(12.8) 74.4(13.1) 74.6(12.8) 77.7(10.1) 78.2(10.1) 77.7(10.5) 86.4(7.6) 86.9(7.5) 86.9(7.7) 83.4(10.5) 84.2(10.3) 83.6(10.9)
Index of Multiple 
Deprivation
         1- least deprived 22.8% 22.8% 21.8% 14.8% 15.1% 15.0% 23.6% 22.5% 22.0% 20.0% 18.8% 19.6%
         2 25.9% 24.0% 24.9% 21.2% 21.1% 19.0% 25.0% 23.7% 23.0% 24.0% 24.7% 25.4%
         3 20.8% 21.9% 20.2% 17.7% 19.5% 19.6% 21.9% 22.5% 23.1% 22.0% 22.1% 22.8%
         4 17.3% 17.8% 18.7% 22.8% 21.7% 23.0% 16.8% 17.1% 16.4% 18.6% 19.1% 17.6%
         5-most deprived 13.1% 13.5% 14.3% 23.3% 22.5% 23.3% 12.6% 14.2% 15.4% 15.4% 15.3% 14.6%
Palliative Care- Yes(%) 57.6% 60.2% 61.7% 13.4% 17.3% 22.6% 16.1% 30.5% 41.4% 13.0% 16.8% 24.2%
        QOF Codes 50.1% 52.1% 52.1% 8.4% 11.0% 14.3% 9.7% 17.3% 22.7% 7.1% 9.8% 13.9%
        Other Codes 7.5% 8.1% 9.6% 4.9% 6.4% 8.3% 6.4% 13.2% 18.8% 5.9% 7.0% 10.3%
Death in Hospital- Yes(%) 34.7% 35.4% 28.9% 47.1% 51.9% 40.8% 23.7% 25.6% 20.5% 42.8% 48.5% 41.0%
Index of Multiple Deprivation and place of death were available for 81% of deaths.
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Table 2: Proportions and changes in proportion of deaths recorded as needing palliative care approach in primary care since 
April 2009-March 2010.





Changes in Proportion 
(95%CI)
Cancer
2009-10 6799 3913 57.6% 57.6%(56.4,58.7%) 0(ref)
2011-12 6386 3845 60.2% 60.6%(59.5,61.8%) 2.97%(1.33,4.62%)
2013-14 5483 3381 61.7% 61.9%(60.6,63.2%) 4.44%(2.74,6.14%)
Annual Change 1.12%(0.70,1.54%)
COPD
2009-10 1924 257 13.4% 13.6%(11.9,15.3%) 0(ref)
2011-12 1872 324 17.3% 17.5%(15.4,19.6%) 4.08%(1.82,6.34%)
2013-14 1630 368 22.6% 21.2%(19.2,23.3%) 9.36%(6.85,11.9%)
Annual Change 2.31%(1.70,2.92%)
Dementia
2009-10 2433 391 16.1% 20.9%(17.8,23.9%) 0(ref)
2011-12 2474 755 30.5% 37.5%(33.8,41.1%) 14.6%(12.3,16.9%)
2013-14 2432 1008 41.4% 40.7%(37.2,44.2%) 25.4%(22.9,27.8%)
Annual Change 6.43%(5.82,7.04%)
Heart Failure
2009-10 2429 315 13.0% 12.6%(10.7,14.4%) 0(ref)
2011-12 2152 361 16.8% 15.0%(12.8,17.2%) 3.26%(1.20,5.32%)
2013-14 1828 443 24.2% 21.2%(18.7,23.8%) 10.7%(8.38,13.1%)
Annual Change 2.56%(1.99,3.12%)
Adjusted proportions were standardised to the age- and sex- distribution of persons with cancer who died between April 
2009 and March 2010.  Changes in proportions and 95% confidence intervals (95%CI) were estimated using binomial 
regression adjusted for age, sex and index of multiple deprivation. 
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Table 3: Changes in proportion of deaths in hospital since April 2009-March 2010 among all patients, and among those not recorded or recorded as needing palliative care.  














Proportion Change in Proportion
(95%CI)
Cancer
2009-10 1929/5565 34.6% 0(ref) 1076/2371 45.4% 0(ref) 853/3194 26.7% 0(ref)
2011-12 1842/5200 35.4% 0.69%(-1.11,2.49%) 1033/2094 50.7% 5.33%(2.41,8.26%) 781/3106 25.1% -1.47%(-3.63,0.69%)
2013-14 1277/4426 28.9% -5.69%(-7.73,-4.08%) 727/1694 42.9% -2.56%(-5.65,0.53%) 550/2732 20.1% -6.32%(-8.47,-4.18%)
Annual Change -1.43%(-1.90,-0.97%) -0.45%(-1.23,0.32%) -1.62%(-2.19,-1.05%)
COPD
2009-10 734/1557 47.1% 0(ref) 672/1364 49.3% 0(ref) 62/193 32.1% 0(ref)
2011-12 795/1531 51.9% 4.75%(1.23,8.28%) 711/1272 55.9% 6.57%(2.76,10.4%) 84/259 32.4% 0.38%(-8.36,9.11%)
2013-14 537/1315 40.8% -6.25%(-9.88,-2.62%) 456/1022 44.6% -4.60%(-8.63,-0.56%) 81/293 27.6% -4.47%(-12.8,3.89%)
Annual Change -1.46%(-2.38,-0.55%) -0.93%(-1.94,0.08%) -1.24%(-3.34,0.86%)
Dementia
2009-10 463/1951 23.7% 0(ref) 426/1655 25.7% 0(ref) 37/296 12.5% 0(ref)
2011-12 519/2025 25.6% 1.77%(-0.86,4.40%) 463/1417 32.7% 6.84%(3.63,10.1%) 56/608 9.2% -2.07%(-6.17,2.03%)
2013-14 401/1953 20.5% -2.99%(-5.54,-0.45%) 340/1135 30.0% 4.03%(0.66,7.40%) 61/818 7.5% -3.74%(-7.64,0.16%)
Annual Change -0.78%(-1.44,-0.12%) 1.21%(0.34,2.07%) -0.90%(-1.74,-0.06%)
Heart Failure
2009-10 865/2022 42.8% 0(ref) 797/1759 45.3% 0(ref) 68/263 25.9% 0(ref)
2011-12 865/1783 48.5% 5.89%(2.74,9.05%) 779/1500 51.9% 6.72%(3.30,10.1%) 86/283 30.4% 5.14%(-2.37,12.6%)
2013-14 599/1462 41.0% -1.26%(-4.55,2.03%) 513/1127 45.5% 0.71%(-2.99,4.40%) 86/335 25.7% 1.18%(-5.81,8.17%)
Annual Change -0.14%(-0.97,0.69%) 0.43%(-0.50,1.35%) 0.19%(-1.62,2.00%)
Change in proportions and 95% confidence intervals (95%CI) were estimated using binomial regression adjusted for age, sex and index of multiple deprivation.
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Figure 1: Flow diagram of identification of study subjects from CPRD GOLD. 
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Figure 2: Distribution of time before death when palliative care first recorded in primary care notes by 
disease and year. 
Page 19 of 40
https://mc.manuscriptcentral.com/bmjspcare





























































Confidential: For Review Only
Supplemental Table 1: Read codes, Medcodes and Read terms used to identify patients needing palliative care.  
Read Code Medcode Read Term 
QOF Palliative Care Codes   
1Z01. 26353 Terminal illness - late stage 
2JE.. 100660 Last days of life 
38QH. 108509 Palliative Care Outcomes Collaboration Assessment Toolkit 
38QK. 108547 Palliative Care Problem Severity Score 
8B2a. 106667 Prescription of palliative care anticipatory medication 
8BA2. 6664 Terminal care 
8BAe. 98251 Anticipatory palliative care 
8BAP. 10019 Specialist palliative care 
8BAS. 49651 Specialist palliative care treatment - daycare 
8BAT. 26354 Specialist palliative care treatment - outpatient 
8BJ1. 18551 Palliative treatment 
8BMM.00 97066 Issue of palliative care anticipatory medication box 
8BMM.11 97280 Issue of palliative care just in case box 
8CM1.% (excluding 8CM15) 12739 On gold standards palliative care framework 
8CM1000 100607 GSF supportive care stage 1 - advancing disease 
8CM1100 100525 GSF supportive care stage 2 - increasing decline 
8CM1200 101636 GSF supportive care stage 3 - last days: cat C - weeks prognosis 
8CM1300 100466 GSF supportive care stage 3 - last days: cat D - days prognosis 
8CM1400 102415 GSF supportive care stage 3 - last days: cat B - month prognosis 
8CM1600 105306 GSF prognostic indicator stage B (green) - months prognosis 
8CM1700 105314 GSF prognostic indicator stage C (yellow) - weeks prognosis 
8CM1800 105447 GSF prognostic indicator stage D (red) - days prognosis 
8CM4 74909 Liverpool care pathway for the dying 
8CMb. 106662 Integrated care priorities for end of life 
8CME. 99766 Has end of life advance care plan 
8CMQ. 104282 On Liverpool care pathway for the dying 
8CMW3 105222 End of life care pathway 
8H6A. 26352 Refer to terminal care consult 
8H7g 9755 Referral to palliative care service 
8H7L 34531 Refer for terminal care 
8HH7. 22288 Referred to community specialist palliative care team 
8IEE. 103941 Referral to community palliative care team declined 
9367 105961 Patient held palliative care record 
9c0L0 105908 Planned palliative oncology treatment 
9c0M. 106204 Planned supportive care for terminal illness 
9c0N. 107583 Current supportive care for terminal illness 
9c0P. 105975 Current palliative oncology treatment 
9EB5. 6924 DS 1500 Disability living allowance completed 
9G8.. 105757 Ambulance service notified of patient on EoL care register 
9K9.. 105391 Palliative care handover form completed 
9Ng7. 100126 On end of life care register 
9NgD. 104463 Under care of palliative care service 
9NNd. 105214 Under care of palliative care specialist nurse 
9NNf0 106582 Under care of palliative care physician 
ZV57C 7060 [V]Palliative care 
Other Codes   
13VH.00 6277 Has made a living will 
1R1..00 36918 Not for resuscitation 
1Z0..00 8976 Terminal illness 
1Z00.00 41446 Terminal illness - early stage 
2JL.00 102557 Imminent expected death 
67Q..00 103607 Counselling for end of life issues 
8BAN.00 11318 Community specialist palliative care 
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8BAO.00 11017 Pain and symptom management 
8BAQ.00 38123 Final days pathway 
8BAR.00 10784 Specialist palliative care treatment - inpatient 
8BC1.00 18732 Treatment plan given 
8BC4.00 18468 Syringe driver commenced 
8CM3.00 19458 Palliative care plan review 
8CN0.00 38948 Preferred place of death discussed with significant other 
8CN1.00 19317 Preferred place of death discussed with patient 
8Hg0.00 50291 Discharged from community specialist palliative care team 
8HgX.00 106695 Discharge from palliative care service 
8HY..00 22073 Referral to hospice 
94Z0.00 35269 Preferred place of death 
94Z1.00 30609 Preferred place of death: home 
94Z2.00 30690 Preferred place of death: hospice 
94Z3.00 54781 Preferred place of death: community hospital 
94Z4.00 52434 Preferred place of death: hospital 
94Z5.00 23076 Preferred place of death: nursing home 
94Z6.00 100767 Preferred place of death: patient unable to express preference 
94Z7.00 103360 Preferred place of death: discussion not appropriate 
94Z8.00 101701 Preferred place of death: patient undecided 
94ZB.00 100468 Preferred place of death: discussed with family 
94ZC.00 101152 Preferred place of death: care home 
94ZD.00 106038 Preferred place of death: patient declined discussion 
94ZE.00 104115 Preferred place of death: residential home 
94ZF.00 104566 Preferred place of death: usual place of residence 
9b9B.00 73313 Palliative medicine 
9e0..00 30696 GP out of hours service notified 
9e00.00 50371 GP out of hours service notified of cancer care plan 
9e01.00 100171 Notification to primary care OOHS of anticipated death 
9e02.00 98441 Notify to primary care OOHS of palliative care plan in place 
9hB.00 62309 Exception reporting: palliative care quality indicators 
9hB0.00 30643 Excepted from palliative care quality indicators: Patient unsuitable? 
9ke..00 97051 Palliative care - enhanced services administration 
9Nh0.00 48775 Under the care of community palliative care team 
9NIJ.00 96936 Seen by palliative care service 
9NNa.00 103569 Has end of life care pathway key general practitioner 
9NNb.00 105849 Has end of life care pathway key nurse 
9NNZ.00 102536 Has end of life care pathway key worker 
9Ok5.00 26076 Cancer pain and symptom management 
9X0..00 47226 Advanced directive discussed with patient 
9X1..00 17854 Advanced directive discussed with relative 
9X2..00 36511 Advanced directive signed 
9X2..11 101060 Advance decision signed 
9X20.00 25562 Advanced directive signed (copy in notes) 
9X20.11 107192 Advance directive signed (copy in notes) 
Z172.00 9996 Palliative care 
Z1FC.00 30193 Preferences relating to death and dying 
Z1FC600 58623 Preference for informing others of terminal diagnosis 
Z4I4100 59644 Exploring patient's feelings about dying 
ZL18R00 28899 Under care of palliative care physician 
ZL5AP00 13628 Referral to palliative care physician 
ZL9AR00 11978 Seen by palliative care physician 
ZLD3R00 11134 Discharge by palliative care physician 
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Supplementary Table 1: Proportions and changes in proportion of deaths as needing palliative care approach in primary 
care, and days between palliative care registration and death, since April 2009-March 2010 among patients with more than 
one of chronic pulmonary obstructive disease, dementia or heart failure, or among patients with any one or more of these 
conditions as well as cancer. 












       
Multiple excl. Cancer      
 Apr2009-Mar2010 1095 161 14.7% 14.1%(10.8,17.3%) 0(ref) 117(15-793) 
 Apr2011-Mar2012 1097 270 24.6% 22.2%(18.3,26.0%) 9.30%(6.01,12.6%) 112(13-668) 
 Apr2013-Mar2014 919 291 31.7% 26.9%(22.8,30.9%) 16.2%(12.5,19.9%) 316(40-800) 
Annual Change     4.13%(3.21,5.04%)  
       
Multiple incl. Cancer      
 Apr2009-Mar2010 2215 998 45.1% 51.8%(48.9,54.6%) 0(ref) 127.5(30-377) 
 Apr2011-Mar2012 2219 1079 48.6% 54.1%(51.5,56.7%) 3.54%(0.63,6.45%) 103(25-396) 
 Apr2013-Mar2014 2086 1161 55.7% 58.1%(55.2,61.0%) 10.5%(7.58,13.5%) 150(33-485) 
Annual Change     2.62%(1.89,3.36%)  
Adjusted proportions were standardised to the age- and sex- distribution of persons with cancer who died between April 
2009 and March 2010.  Change in proportions and 95% confidence intervals (95%CI) estimated using binomial regression, 
and were adjusted for age, sex and index of multiple deprivation.  
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Supplemental Table 3: Proportions (%) and annual percentage changes in palliative care registration between persons of 
different sex, age or index of multiple deprivation by disease and year.  
  March 2009-April 2010 March 2011-April 2012 March 2013-April 2014   
  
Proportion Proportion Proportion 
Annual Percent 
Change (95%CI) Unadj. Adjusted (95%CI) Unadj Adjusted (95%CI) Unadj. Adjusted (95%CI) 
 
COPD  




Male 11.6 11.4(9.4,13.4) 15.5 14.4(12.2,16.5) 22.2 21.7(18.9,24.5) 2.60(1.80,3.40) 
Female 15.4 15.8(13.1,18.6) 19.6 20.8(17.2,24.3) 23.0 20.7(17.7,23.7) 1.90(0.95,2.85) 
Age   
<70 15.4 14.9(11.2,18.6) 17.2 17.8(13.0,22.6) 16.9 15.5(11.5,19.4) 0.49(-0.85,1.82) 
70-79 12.5 12.7(9.9,15.4) 17.2 17.2(14.1,20.4) 24.8 24.8(21.0,28.6) 3.17(2.06,4.28) 
80-89 12.3 12.4(10.0,14.8) 15.6 15.5(12.9,18.2) 23.2 23.1(19.8,26.5) 2.56(1.60,3.52) 
≥90 15.6 15.3(10.2,20.4) 23.3 23.7(17.8,29.5) 25.0 25.6(19.2,32.0) 2.39(0.31,4.47) 
IMD   
1-least deprived 17.3 15.6(10.8,20.4) 21.7 19.7(14.5,24.9) 27.9 25.1(19.0,31.3) 2.64(0.70,4.58) 
2 13.0 11.9(8.4,15.4) 16.1 15.1(10.9,19.3) 23.2 23.3(17.7,28.9) 2.34(0.84,3.84) 
3 12.3 12.9(9.0,16.9) 14.8 16.8(12.8,20.9) 23.3 21.0(15.8,26.2) 2.58(1.07,4.09) 
4 11.8 12.8(9.1,16.4) 19.3 19.2(14.3,24.0) 20.2 19.8(15.5,24.0) 2.39(0.93,3.84) 
5-most deprived 9.4 9.3(6.4,12.3) 14.2 15.0(11.1,18.9) 19.3 17.8(13.9,21.7) 2.49(1.20,3.79) 
Missing 17.3 17.4(13.0,21.8) 19.0 21.8(17.9,25.8) 23.7 23.2(18.8,27.7) 1.53(0.06,2.99) 
 
Dementia  
Overall 16.1 20.9(17.8,23.9) 30.5 37.5(33.8,41.1) 41.4 40.7(37.2,44.2) 6.43(5.82,7.04) 
Sex   
Male 14.8 16.5 (12.0,21.0) 30.2 37.6(32.5,42.6) 36.2 33.4(28.9,38.0) 5.63(4.56,6.70) 
Female 16.7 25.4(21.4,29.5) 30.7 37.4(32.2,42.5) 43.9 48.3(43.0,53.5) 6.83(6.09,7.57) 
Age   
<70 22.6 28.9(21.1,36.8) 39.4 49.3(40.2,58.4) 39.7 43.8(35.3,52.4) 4.55(0.52,8.57) 
70-79 19.0 19.4(14.8,24.1) 34.7 35.3(29.4,41.3) 39.8 38.8(32.9,44.7) 5.53(3.74,7.33) 
80-89 15.5 14.9(12.7,17.1) 27.5 27.7(24.8,30.5) 39.6 38.6(35.5,41.6) 6.05(5.17,6.92) 
≥90 15.2 14.5(11.8,17.1) 32.2 31.3(28.0,34.6) 44.0 41.8(38.3,45.2) 7.22(6.23,8.21) 
IMD   
1- least deprived 18.0 18.3(13.7,23.0) 30.9 22.8(17.1,28.6) 42.8 29.6(22.9,36.3) 6.25(4.80,7.70) 
2 12.7 11.7(6.8,16.6) 29.8 27.9(22.8,32.9) 43.6 41.1(35.5,46.7) 7.78(6.43,9.11) 
3 17.0 18.0(14.7,21.3) 30.3 30.0(25.0,35.0) 43.6 38.4(31.9,45.0) 6.65(5.22,8.09) 
4 14.9 11.2(6.5,15.9) 28.6 27.9(21.7,34.1) 33.1 28.9(21.6,36.1) 4.82(3.16,6.48) 
5- most deprived 11.8 7.7(4.3,11.2) 30.3 28.6(22.1,35.1) 44.5 32.2(26.7,37.7) 8.22(6.49,9.94) 
Missing 19.7 23.5(17.9,29.1) 32.7 33.5(27.4,39.6) 39.8 41.7(36.3,47.0) 5.08(3.66,6.50) 
 
Heart Failure  




Male 11.8 11.4(9.3,13.6) 16.7 14.0(11.7,16.3) 22.9 21.0(17.9,24.1) 2.60(1.81,3.39) 
Female 14.0 13.7(10.6,16.9) 16.9 16.0(12.2,19.9) 25.6 21.5(17.4,25.5) 2.51(1.72,3.31) 
Age   
<70 12.3 12.6(8.0,17.2) 9.7 11.3(6.1,16.4) 18.9 19.5(13.5,25.4) 1.44(-0.10,3.00) 
70-79 11.7 11.3(8.3,14.3) 17.5 17.3(13.2,21.5) 18.1 17.9(13.6,22.2) 1.76(0.43,3.10) 
80-89 14.1 13.9(11.8,16.0) 16.4 16.1(13.6,18.5) 23.9 23.9(20.8,27.1) 2.23(1.36,3.11) 




1- least deprived 16.8 17.4(11.9,23.0) 17.3 9.5(6.2,12.7) 24.1 17.1(12.4,21.7) 1.55(0.10,2.99) 
2 12.8 9.7(6.7, 12.6) 17.2 14.0(11.4,16.7) 22.1 17.6(12.5,22.8) 2.27(1.02,3.53) 
3 13.1 11.6(8.2,15.1) 18.3 17.3(13.2,21.5) 23.7 21.3(15.8,26.9) 2.54(1.20,3.88) 
4 9.8 9.0(4.9,13.1) 10.6 13.7(8.0,19.5) 21.3 18.1(12.4,23.8) 2.47(1.20,3.74) 
5- most deprived 12.2 11.3(7.5,15.1) 15.1 14.2(9.7,18.8) 23.5 21.6(15.2,28.1) 2.43(0.88,3.97) 
Missing 12.8 13.3(8.1,18.5) 21.1 18.2(13.6,22.9) 29.4 24.6(18.8,30.4) 4.09(2.70,5.48) 
  
      
  Adjusted proportions were standardised to the age- and sex- distribution of persons with cancer who died between April 
2009 and March 2010.  Annual changes with 95 confidence intervals (95%CI) were estimated using binomial regression 
adjusted for sex, age and index of multiple deprivation as appropriate. 
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Whilst guidelines recommend palliative care in non-cancer conditions, this has not been widely 
implemented. We examined whether the recording of a palliative care approach and the numbers of 
hospital deaths for deceased patients with heart failure, dementia, chronic obstructive pulmonary 
disease (COPD) and cancer have changed since the UK End of Life Care Strategy was introduced.
Methods
We conducted sequential cross-sectional studies of decedents within the UK’s Clinical Practice 
Research Datalink and Hospital Episode Statistics.  All adults with a primary care record of COPD 
(N=5,426), dementia (N=7,339), heart failure (N=6,409) or cancer (N=18,668) who died during three 
one-year periods (April 2009-March 2014) were included. Evidence of a palliative care approach was 
identified from primary care records, and death in hospital from secondary care data.  
Results
From 2009 to 2014, proportions with a primary care record of palliative care increased for COPD 
from 13.6% to 21.2%; dementia from 20.9% to 40.7%; and heart failure from 12.6% to 21.2%; but 
remained substantially lower than for cancer (57.6% to 61.9%).  Median days before death of 
recording improved for COPD (145 to 224) and dementia (44 to 209); but not for heart failure (168.5 
to 153) and cancer (123 to 114).  Trends in hospital deaths were not consistently downward, 
although the proportions of patients dying in hospital were lower in the last period compared to the 
first.
Conclusions
Recording of a palliative care approach for non-cancer conditions has increased since the 
introduction of the UK End of Life Care Strategy, but remains inadequate. 
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3
Introduction
A palliative approach to care is important not only in cancer but in non-malignant conditions where 
patients have palliative care needs comparable to those of cancer patients [1].  Among the most 
common conditions identified by the World Health Organisation as diseases that would benefit from 
palliative care are heart failure (HF), dementia and chronic obstructive pulmonary disease (COPD) 
[2]. Such conditions carry a similar symptom burden and poor quality of life for patients and their 
families and friends, but there is evidence from the United States [3,4], and the United Kingdom (UK) 
[5] that these needs are less likely to be met.  
In the UK, the introduction  of a national End-of-Life Care Strategy in 2008 [6] represented a major 
policy shift to extend specialist palliative care regardless of diagnosis, to be delivered primarily by 
generalists, with access to specialist palliative care services for persistent or complex problems.  
Although the role of primary care is central to providing palliative care to those nearing the end of 
life, information on whether the need is being met in the UK is sparse, despite maintenance of a 
palliative care register by general practitioners being incentivised as part of the Quality and 
Outcomes Framework (QOF) since 2006 [7].  Using general practice-based registers of palliative care, 
one study conducted shortly after the Strategy’s introduction, found patients with HF were poorly 
represented on the register, and when recorded, registration was often within a week of death [8].  
Using the same electronic datasource, Bloom and colleagues showed that whilst the proportion of 
people dying from COPD and receiving palliative care increased between 2005 and 2015, this 
remained disproportionately low in those dying with COPD only (16.5%) compared with those dying 
with COPD and cancer (56.5%) [9].  Although from simple observation, the rate of change appears to 
increase from 2011. 
With the aim of exploring whether recording of palliative care in primary care has changed for non-
cancer conditions since 2008, patients who died with HF, dementia, or COPD, and for comparison, 
patients who died with cancer, in three different years were identified in UK’s Clinical Practice 
Research Datalink (CPRD) [10].  Using information in their healthcare records, potential changes in 
palliative care recording as well as the prevalence of hospital deaths were explored. 
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Materials and Methods
Patients aged 18 or over with at least one clinical record of COPD; dementia; heart failure; or cancer 
(excluding non-melanoma skin cancer) who died in the periods 1 April 2009 to 31 March 2010; 1 
April 2011 to 31 March 2012; or 1 April 2013 to 31 March 2014, were identified in CPRD using Read 
codes described in the NHS’s Quality and Outcomes Framework (QOF) (QOF version 29, June 2014) 
[11]. The CPRD is a database of contemporaneous medical records from UK primary care and is 
demographically representative, covering around c.7% of the UK population [10]; the QOF is a 
voluntary incentive scheme for general practitioners in the UK [7].  Fact and date of death recorded 
in primary care records, which have shown a high level of agreement with national death 
certification, were used to identify patients who had died [12].  Focus was primarily on patients who 
had only one of these conditions; where two or more were recorded, patients were considered in 
two additional groups based on whether or not they had cancer.  Patients were included if they had 
at least one year of records and met CPRD acceptability criteria for data quality; for sensitivity 
analyses, subgroups of patients were established based on whether conditions were recorded either 
within five years of, or in the year before, death.
The palliative care register that has been part of QOF since 2006 covers clinical terms relating to 
palliative care services; advance care directives, recording of preferred place of death, indication of 
terminal illness and similar care near the end of life are not covered.  Therefore, a comprehensive 
list of Read codes that reflected recognition of the need for end of life care was developed 
(Supplementary Table 1).  Patients were considered as recognised as needing palliative approach if 
any of these codes appeared in their primary care records; in addition, the time between the earliest 
recording of any palliative care code and their death was calculated.  Where no palliative care codes 
were recorded, patients were considered as not being recognised as needing palliative approach.
Information on whether patients died in hospital was obtained from secondary care data, which was 
available for 81% of the cohorts who had consented for linkage of CPRD to HES.  From their HES 
records, it was possible to determine whether a patient had died in hospital; otherwise, patients 
were assumed to have died outside hospital.  Patients with no consent for linkage were excluded 
from the analysis of death in hospital.
Proportions recognised as requiring a palliative approach were calculated, and in order to be 
comparable to cancer patients, were standardised to the age- and sex-distribution of cancer patients 
who died in the first year of the study (April 2009-March 2010).  Annual changes in proportions, with 
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5
95% confidence intervals (CI), were estimated using binomial regression; annual changes in 
proportions were assumed to be linear since all tests for departure from linearity were not 
statistically significant.  All analyses were conducted using Stata 14.2.  
Results
Figure 1 shows how the 47 473 patients included in the sequential cross-sectional studies were 
identified in CPRD, and Table 1, the expected between-disease differences in age and sex 
distributions.  For all conditions except cancer, palliative care codes outside QOF were used as often 
as those in QOF, and hence the totality was used in all presented analyses.
In the first year of our study, around three in every 20 patients with COPD, HF or dementia were 
recorded with a code recognising a palliative approach, compared to 12 in every 20 cancer patients 
(Table 2).  By the final period, April 2013 to March 2014, proportions had increased to four in every 
20 patients with COPD; eight in every 20 with dementia; and five in every 20 with HF.  Palliative care 
recording increased most for patients with dementia, growing by 6.4% per year (95%CI 5.8, 7.0%); 
followed by HF at 2.6% (95%CI 2.0, 3.1%); and COPD at 2.3% (95%CI 1.7, 2.9%).  Over the same 
period, recording among cancer patients grew by 1.1% (95%CI 0.7, 1.5%).  For patients with two or 
more conditions, those without cancer saw an increase from three to six in every 20 patients being 
recorded, and those with cancer from nine to 11 in every 20 (Supplementary Table 2).  Repeating 
analyses with patients whose conditions were recorded within the 5-year or 1-year period before 
death gave marginally greater proportions, mostly due to a smaller number of patients contributing 
to the denominator, but the annual change over time remained the same (data available on 
request).  As for the timing of recording, this changed over the study period (Figure 2).  In the year 
2009-10, 35.8% with dementia and palliative care noted, 22.0% with HF and 16.0% with COPD were 
recorded for the first time in the week before death.  By 2013-14, this had reduced to 17.5%, 15.6% 
and 13.3% for dementia, HF and COPD respectively, becoming closer to the 8-10% of patients with 
cancer.
Palliative care recording generally increased among men and women; in all age groups; and across 
all deprivation categories (Supplemental Table 3).  Overall, proportions with palliative care recorded 
were similar for men and women; however, for dementia, sex-specific proportions diverged such 
that by 2013-14, 43.9% of women compared to 36.2% of men had palliative care recorded.  With 
regards to age, some of the largest increases occurred in those aged 90 or over, with annual change 
estimated at 2.4% (95%CI 0.3, 4.5%) for COPD, and ranging up to 7.2% (95%CI 6.2, 8.2%) for 
dementia.  On the other hand, patients aged under 70 did not see an increase in recording, and for 
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COPD in particular, where around a fifth of deaths occurred in the under 70-year olds, palliative care 
recording was lower than for those aged 70-79, at 16.9% compared to 24.8% in the last period.  For 
those living in more deprived areas, proportions of palliative care recording tended to be lower than 
amongst those from the most affluent, but not always significantly so.
Proportions of patients dying in hospital increased initially before falling in 2013-14, being 
significantly lower in the last year than in the first for cancer, COPD, and dementia but not HF (Table 
3).  When considering whether patients had a primary care record of palliative care, fewer with a 
record died in hospital than those who did not.  Over the course of the study, the only condition 
apart from cancer where the proportions with palliative care who died in hospital decreased was 
dementia.  Repeating the analysis restricted to QOF palliative care register codes, or where patients 
whose first record of palliative care was in the week before death were removed, gave similar 
findings (data not shown).
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Discussion 
Summary of main findings 
It is encouraging that the recognition of the need for palliative care approach has increased in those 
with non-cancer diseases since the introduction of the UK End of Life Care Strategy.  Not only have 
the proportions increased, but the timeliness of recording has also changed, with fewer patients 
registered in the week before death.  Despite the improvements, significant inequalities remain; 
most notably that decedents with these conditions remain less likely to be recorded as having 
palliative care needs than those with cancer.  With regards to dying in hospital, the data suggest that 
the numbers have decreased, particularly among those with palliative care, but a longer trajectory is 
needed to confirm these observations.
Registration on the palliative care QOF is a proxy measure for clinical recognition of the need for a 
palliative approach to care.  Since the introduction of this indicator in 2006, over 99% of practices 
use a palliative care register [7].  Despite clear guidance, there may be a perception that the 
palliative care QOF is for cancer patients.  Interestingly though, not only did the use of QOF palliative 
care codes in the non-malignant conditions increase, but also other non-QOF codes relating to end 
of life care such as advanced care directives were used as often throughout the data.  Some of the 
biggest increases in recording were among patients aged 90 or older.  Socioeconomic differences in 
palliative care were present to a degree, with more deprived patients less likely to have a record of 
palliative care than those who were more affluent; however, among the factors we were able to 
examine, age and GP practice may have been more influential on the recording. 
Comparison with literature 
A realist evaluation of 16 GP Practices showed improvement over time in recognition of palliative 
care in non-cancer conditions following the introduction of a palliative care pathway but, as found 
here, the inequity of lower recognition of palliative care in non-cancer conditions compared to 
cancer remained [13].  Our findings are consistent with the other CPRD study showing that 
recognition of a palliative care approach was driven by a lung cancer diagnosis rather than COPD 
itself [9].  Our slightly higher proportion categorised as palliative care may be because of our use of 
palliative care registration rather than Read codes only.  Other studies have shown a reduction in 
hospital deaths, in both cancer and non-cancer conditions [14–16]. The reasons for these changes 
are likely to be multifactorial: the Strategy and its wider policy influence; public health initiatives; 
increased clinical education and more publications and awareness regarding palliative care for non-
cancer conditions. For reduced hospital deaths in dementia, factors such as economic incentives to 
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reduce hospital admissions and stays have been suggested as a factor in the UK, other European 
countries and the US and have resulted in more deaths in care homes [16]. This study did not 
explore death outside of hospital but a study of hospice deaths from 1993–2012 demonstrated an 
increase in non-cancer conditions among hospice decedents although absolute numbers remain 
small [17]. 
 
Strengths and limitations 
This study benefits not only from being population-based in a large primary care dataset, but also 
from having as its basis the contemporaneous recording of conditions and care by general 
practitioners and health care professionals.  We were able to identify decedents who had a record of 
the conditions of interest in their primary care notes, rather than relying on causes of death on the 
death certificates which are k own to be inaccurate [18].  Moreover, the conditions of interest-  
cancer, heart failure, dementia and COPD - are QOF indicators, whereby GPs are incentivised to 
maintain the disease registers and record diagnoses once confirmed using specific tests and 
assessments, and have proved reliable for population-based prevalence data [19].  One limitation is 
that since primary care notes were established across patients’ lifetimes, the disease may not have 
been relevant to the patient’s death, and our denominator may be overestimated.  However, 
analyses including only those whose disease was recorded in the last five or final year of life, whilst 
finding slightly higher proportions of palliative care recording showed very similar patterns.  A 
limitation of the cross-sectional design is that general practices contributing to CPRD can change 
over time; restricting the analyses to the 42618 decedents (89.8%) whose practices contributed to 
all three periods did not alter the findings (data not shown).  Many of the general practices 
contributing to CPRD are located in the North West or South East of England, and of smaller practice 
size than the national average [20,21]; however, in terms of the patients, the 7% of the UK 
population in CPRD are generally representative of the total population [10].
Identification of a palliative care approach in this study is dependent on coding in the clinical record; 
whilst a broader range of codes was used than in some recent studies [8,9], it is likely that we have 
under-estimated true palliative care activity. However, systematic differences in this under-
estimation by condition seem unlikely and hence the relative differences observed would remain 
robust. 
Information on place of death is not routinely available in primary care records in CPRD and was 
established from secondary care data. We were therefore only able to define whether patients died 
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in hospital or not; information on deaths at home or hospice were unavailable.  While we had only 
three alternate years of data available due to limitations of funding, this was sufficient to see an 
upward time trend in palliative care recording, described as linear growth but not of sufficient 
duration to assess alternative trend patterns; and when compounded by low palliative care 
recording, to determine clear patterns in hospital deaths.  We also recognise that place of death in 
isolation should not be a quality marker of good care of the dying. Measures such as patient centred 
outcome measures (PCOMs) are increasingly seen as the gold standard for measuring quality of care 
but were not available and indeed are not widely used [22].  Although we relate our discussion to 
the UK End of Life Strategy of 2008, we are unable to assume causality in this observational study 
and data prior to 2008 were not analysed for comparison. Of interest, the rate of increase for COPD 
patients (2.3% per year) is similar to the rate of increase between 2008 to 2014 reported in Bloom et 
al, and which is approximately twice the rate of increase in their 2005 to 2008 data although they 
did not evaluate this [9].
Implications for research, policy and practice 
Although inequities seem to be improving for all disease further investigation of the reasons for and 
how to overcome the inequality are needed: for example, a case study approach of practices with 
low and high proportions of patients on the palliative care register.  Also a study to explore more 
patient-centred outcomes of the result of being on a palliative care register especially as these 
become more widely used, for example the Integrated Palliative care Outcome Scale (IPOS), a
patient centred outcome measure developed and validated for use with people with advanced 
disease [22]. 
We would challenge the current UK strategy for identification of palliative care patients based on 
“end of life”.  Although the UK policy definition does not intend an interpretation of “the last few 
days or weeks of life”, in practice, that is often the case. The use of the word “end” strongly implies a 
time-bound frame, and one which works backwards from the time of death. This risks delay in 
implementing a palliative approach, arising from the real challenges of accurately predicting the day 
of death, so called “prognostic paralysis” [23], a problem that is also well recognised as a barrier to 
hospice care for non-cancer diagnoses in the United States [24].  We welcome initiatives that 
promote supportive care and advance care planning earlier in the disease trajectory [25].  The more 
recent national framework for local implementation UK Ambitions of Care document uses the 
phrase “palliative and end-of-life” [26]. It will be interesting to see whether this clarifies or 
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complicates clinical practice. We look to the WHO and Worldwide Palliative Care Alliance which do 
not mention either diagnosis, or prognosis, rather using the term life-limiting conditions and 
recommends  identification of need for palliative care based on symptoms [2]. 
Conclusions 
To the best of our knowledge this is the first use of this data linkage in the palliative care population 
and allowed us to explore not only recognition of palliative care in primary care. Since the 
introduction of the UK End of Life Care Strategy recognition of the need for palliative care approach 
has increased in common life-limiting conditions, in a timelier manner.  This may have in turn been 
related to a reduction in the number of patients dying in hospital but further study will be needed to 
confirm this.
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Figure Legends
Figure 1: Flow diagram of identification of study subjects from CPRD GOLD.
Figure 2: Distribution of time before death when palliative care first recorded in primary care notes 
by disease and year.
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Table 1: Demographics of persons with cancer, chronic obstructive pulmonary disease (COPD), dementia, or heart failure in their general practice records who died in April 2009-March 2010, 
April 2011-March 2012 or April 2013-March 2014.
Cancer COPD Dementia Heart Failure
2009-10 2011-12 2013-14 2009-10 2011-12 2013-14 2009-10 2011-12 2013-14 2009-10 2011-12 2013-14
Annual Deaths 6799 6386 5483 1924 1872 1630 2433 2474 2432 2429 2152 1828
Sex- Male(%) 51.0% 51.3% 50.4% 53.8% 55.7% 54.4% 32.3% 32.1% 32.0% 47.3% 47.6% 50.2%
Age- Mean(sd) 74.1(12.8) 74.4(13.1) 74.6(12.8) 77.7(10.1) 78.2(10.1) 77.7(10.5) 86.4(7.6) 86.9(7.5) 86.9(7.7) 83.4(10.5) 84.2(10.3) 83.6(10.9)
Index of Multiple 
Deprivation
         1- least deprived 22.8% 22.8% 21.8% 14.8% 15.1% 15.0% 23.6% 22.5% 22.0% 20.0% 18.8% 19.6%
         2 25.9% 24.0% 24.9% 21.2% 21.1% 19.0% 25.0% 23.7% 23.0% 24.0% 24.7% 25.4%
         3 20.8% 21.9% 20.2% 17.7% 19.5% 19.6% 21.9% 22.5% 23.1% 22.0% 22.1% 22.8%
         4 17.3% 17.8% 18.7% 22.8% 21.7% 23.0% 16.8% 17.1% 16.4% 18.6% 19.1% 17.6%
         5-most deprived 13.1% 13.5% 14.3% 23.3% 22.5% 23.3% 12.6% 14.2% 15.4% 15.4% 15.3% 14.6%
Palliative Care- Yes(%) 57.6% 60.2% 61.7% 13.4% 17.3% 22.6% 16.1% 30.5% 41.4% 13.0% 16.8% 24.2%
        QOF Codes 50.1% 52.1% 52.1% 8.4% 11.0% 14.3% 9.7% 17.3% 22.7% 7.1% 9.8% 13.9%
        Other Codes 7.5% 8.1% 9.6% 4.9% 6.4% 8.3% 6.4% 13.2% 18.8% 5.9% 7.0% 10.3%
Death in Hospital- Yes(%) 34.7% 35.4% 28.9% 47.1% 51.9% 40.8% 23.7% 25.6% 20.5% 42.8% 48.5% 41.0%
Index of Multiple Deprivation and place of death were available for 81% of deaths.
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Table 2: Proportions and changes in proportion of deaths recorded as needing palliative care approach in primary care since 
April 2009-March 2010.





Changes in Proportion 
(95%CI)
Cancer
2009-10 6799 3913 57.6% 57.6%(56.4,58.7%) 0(ref)
2011-12 6386 3845 60.2% 60.6%(59.5,61.8%) 2.97%(1.33,4.62%)
2013-14 5483 3381 61.7% 61.9%(60.6,63.2%) 4.44%(2.74,6.14%)
Annual Change 1.12%(0.70,1.54%)
COPD
2009-10 1924 257 13.4% 13.6%(11.9,15.3%) 0(ref)
2011-12 1872 324 17.3% 17.5%(15.4,19.6%) 4.08%(1.82,6.34%)
2013-14 1630 368 22.6% 21.2%(19.2,23.3%) 9.36%(6.85,11.9%)
Annual Change 2.31%(1.70,2.92%)
Dementia
2009-10 2433 391 16.1% 20.9%(17.8,23.9%) 0(ref)
2011-12 2474 755 30.5% 37.5%(33.8,41.1%) 14.6%(12.3,16.9%)
2013-14 2432 1008 41.4% 40.7%(37.2,44.2%) 25.4%(22.9,27.8%)
Annual Change 6.43%(5.82,7.04%)
Heart Failure
2009-10 2429 315 13.0% 12.6%(10.7,14.4%) 0(ref)
2011-12 2152 361 16.8% 15.0%(12.8,17.2%) 3.26%(1.20,5.32%)
2013-14 1828 443 24.2% 21.2%(18.7,23.8%) 10.7%(8.38,13.1%)
Annual Change 2.56%(1.99,3.12%)
Adjusted proportions were standardised to the age- and sex- distribution of persons with cancer who died between April 
2009 and March 2010.  Changes in proportions and 95% confidence intervals (95%CI) were estimated using binomial 
regression adjusted for age, sex and index of multiple deprivation. 
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Table 3: Changes in proportion of deaths in hospital since April 2009-March 2010 among all patients, and among those not recorded or recorded as needing palliative care.  














Proportion Change in Proportion
(95%CI)
Cancer
2009-10 1929/5565 34.6% 0(ref) 1076/2371 45.4% 0(ref) 853/3194 26.7% 0(ref)
2011-12 1842/5200 35.4% 0.69%(-1.11,2.49%) 1033/2094 50.7% 5.33%(2.41,8.26%) 781/3106 25.1% -1.47%(-3.63,0.69%)
2013-14 1277/4426 28.9% -5.69%(-7.73,-4.08%) 727/1694 42.9% -2.56%(-5.65,0.53%) 550/2732 20.1% -6.32%(-8.47,-4.18%)
Annual Change -1.43%(-1.90,-0.97%) -0.45%(-1.23,0.32%) -1.62%(-2.19,-1.05%)
COPD
2009-10 734/1557 47.1% 0(ref) 672/1364 49.3% 0(ref) 62/193 32.1% 0(ref)
2011-12 795/1531 51.9% 4.75%(1.23,8.28%) 711/1272 55.9% 6.57%(2.76,10.4%) 84/259 32.4% 0.38%(-8.36,9.11%)
2013-14 537/1315 40.8% -6.25%(-9.88,-2.62%) 456/1022 44.6% -4.60%(-8.63,-0.56%) 81/293 27.6% -4.47%(-12.8,3.89%)
Annual Change -1.46%(-2.38,-0.55%) -0.93%(-1.94,0.08%) -1.24%(-3.34,0.86%)
Dementia
2009-10 463/1951 23.7% 0(ref) 426/1655 25.7% 0(ref) 37/296 12.5% 0(ref)
2011-12 519/2025 25.6% 1.77%(-0.86,4.40%) 463/1417 32.7% 6.84%(3.63,10.1%) 56/608 9.2% -2.07%(-6.17,2.03%)
2013-14 401/1953 20.5% -2.99%(-5.54,-0.45%) 340/1135 30.0% 4.03%(0.66,7.40%) 61/818 7.5% -3.74%(-7.64,0.16%)
Annual Change -0.78%(-1.44,-0.12%) 1.21%(0.34,2.07%) -0.90%(-1.74,-0.06%)
Heart Failure
2009-10 865/2022 42.8% 0(ref) 797/1759 45.3% 0(ref) 68/263 25.9% 0(ref)
2011-12 865/1783 48.5% 5.89%(2.74,9.05%) 779/1500 51.9% 6.72%(3.30,10.1%) 86/283 30.4% 5.14%(-2.37,12.6%)
2013-14 599/1462 41.0% -1.26%(-4.55,2.03%) 513/1127 45.5% 0.71%(-2.99,4.40%) 86/335 25.7% 1.18%(-5.81,8.17%)
Annual Change -0.14%(-0.97,0.69%) 0.43%(-0.50,1.35%) 0.19%(-1.62,2.00%)
Change in proportions and 95% confidence intervals (95%CI) were estimated using binomial regression adjusted for age, sex and index of multiple deprivation.
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